Session

The small renal mass: Surgery, ablation, complications and relapse

Poster Session 86

  • Location:
    Room Milan (Hall B2, level 0)
  • Chairs:
     T.A. Leslie, Oxford (GB)
     A. Volpe, Torino (IT)
     S. Zastrow, Dresden (DE)
  • Aims and objectives of this session

    Discussion of alternative treatment options and how to deal with complications and relapse.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
1089
Changes in surgical treatment modalities for renal cell carcinoma ≤ 7 cm; A Norwegian population based study 2008-2013

By: Hjelle K.1, Johannesen T.2, Beisland C.1

Institutes: 1Haukeland University Hospital, Dept. of Urology, Bergen, Norway, 2Cancer Registry of Norway, Oslo, Norway

1090
Glomerular volumetric density is reduced after renal radio-frequency ablation as well as after warm ischemia

By: Abreu L., Damasceno-Ferreira J., Pereira-Sampaio M., Gregório B., Costa W., Sampaio F., De Souza D.

Institutes: Rio de Janeiro State University, Dept. of Urogenital Research Unit, Rio de Janeiro, Brazil

1091
Comparing zero ischemia laparoscopic radiofrequency ablation assisted tumor enucleation and laparoscopic partial nephrectomy for clinical T1a renal tumor: A randomized clinical trial

By: Jiwei H., Zhang J., Wang Y., Kong W., Xue W., Liu D., Chen Y., Huang Y.

Institutes: Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Dept. of Urology, Shanghai, China

1092
Imperative indications of nephron sparing technique: Partial nephrectomy vs percutaneous ablative therapy

By: Long J-A.1, Bernhard J-C.2, Bigot P.3, Paparel P.4, Boissier R.5, Rioux-Leclercq N.6, Albiges L.7, Bodin T.8, Nouhaud F-X.9, Gimel P.10, Mejean A.11, Roupret M.12, Masson-Lecomte A.13, Grenier N.14, Cornelis F.14, Grassano Y.15, Comat V.15, Le Clerc Q.C.16, Rigaud J.16, Salomon L.13, Rambeaud J-J.1, Sengel C.17, Verhoest G.18, Patard J-J.19, Bensalah K.18

Institutes: 1Grenoble University Hospital, Dept. of Urology, Grenoble, France, 2Bordeaux University Hospital, Dept. of Urology, Bordeaux, France, 3Angers University Hospital, Dept. of Urology, Angers, France, 4Lyon Sud University Hospital, Dept. of Urology, Lyon, France, 5La Conception University Hospital, Dept. of Urology, Marseille, France, 6Rennes University Hospital, Dept. of Pathology, Rennes, France, 7Institut Gustave Roussy, Dept. of Oncology, Paris, France, 8Centre Prado-Louvain, Dept. of Urology, Marseille, France, 9Rouen University Hospital, Dept. of Urology, Rouen, France, 10Medipole, Dept. of Urology, Cabestany, France, 11Hopital Georges Pompidou, Dept. of Urology, Paris, France, 12La Pitie Hospital, Dept. of Urology, Paris, France, 13Mondor University Hospital, Dept. of Urology, Paris, France, 14Bordeaux University Hospital, Dept. of Radiology, Bordeaux, France, 15Bordeaux University Hospital, Bordeaux, France, 16Nantes University Hospital, Nantes, France, 17Grenoble University Hospital, Dept. of Radiology, Grenoble, France, 18Rennes University Hospital, Dept. of Urology, Rennes, France, 19Kremlin Bicètre University Hospital, Dept. of Urology, Paris, France

1093
Comparison of laparoscopic radio frequency ablation and partial nephrectomy for the treatment of cT1a renal masses

By: Park J.M.1, Lim J.S.1, Na Y.G.1, Kim H.S.2, Song K.H.1

Institutes: 1Chungnam National University School of Medicine, Dept. of Urology, Daejeon, South Korea, 2Konkuk University Chung-Ju Hospital, Dept. of Urology, Chungju, South Korea

1094
Outcomes after laparoscopic assisted renal cryoablation: A retrospective EuRECA multinational analysis

By: Nielsen T.K.1, Lagerveld B.W.2, Keeley F.3, Lughezzani G.4, Sriprasad S.5, Barber N.J.6, Hansen L.U.7, Larcher A.4, Guazzoni G.4, Van Der Zee J.A.2, Ismail M.3, Farrag K.5, Emara A.M.6, Lund L.7, Østraat Ø.8, Borre M.8

Institutes: 1Aarhus University Hospital, Dept. of Urology, Aarhus N, Denmark, 2Onze Lieve Vrouwe Gasthuis, Dept. of Urology, Amsterdam, The Netherlands, 3Bristol Urological Institute, Dept. of Urology, Bristol, United Kingdom, 4Istituto Clinico Humanitas, Dept. of Urology, Milan, Italy, 5Darent Vally Hospital, Dept. of Urology, Dartford, United Kingdom, 6Frimley Park Hospital, Dept. of Urology, Camberley, United Kingdom, 7Odense University Hospital, Dept. of Urology, Odense, Denmark, 8Aarhus University Hospital, Dept. of Urology, Aarhus, Denmark

1095
High nephrometry is an independent predictor for symptomatic renal pseudoaneuryms after open partial nephrectomy

By: Kriegmair M.C.1, Mandel P.2, Rathmann N.3, Diehl S.J.3, Pfalzgraf D.1, Ritter M.1

Institutes: 1Universitätsmedizin Mannheim, Dept. of Urology, Mannheim, Germany, 2University of Hamburg, Dept. of Urology, Hamburg, Germany, 3Universitätsmedizin Mannheim, Dept. of Radiology, Mannheim, Germany

1096
Risk factors for asymptomatic renal artery pseudoaneurysm after partial nephrectomy detected by enhanced CT in the early postoperative period

By: Takagi T.1, Kondo T.1, Omae K.1, Iizuka J.1, Kobayashi H.1, Hashimoto Y.1, Morita S.2, Tanabe K.1

Institutes: 1Tokyo Women’s Medical University, Dept. of Urology, Tokyo, Japan, 2Tokyo Women’s Medical University, Dept. of Diagnostic Imaging and Nuclear Medicine, Tokyo, Japan

1098
Pathogenesis, features and prognosis of renal relapse after partial nephrectomy

By: Antonelli A.1, Sodano M.1, Tardanico R.2, Furlan M.1, Carobbio F.1, Fisogni S.2, Cozzoli A.1, Zanotelli T.1, Simeone C.1

Institutes: 1Spedali Civili Di Brescia, Dept. of Urology, Brescia, Italy, 2Spedali Civili Di Brescia, Dept. of Pathology, Brescia, Italy

1099
Recurrence and relapse after partial nephrectomy for small renal masses

By: Torres Gomez J.J., Vilaseca A., Huguet J., Musquera M., Peri L., García-Cruz E., Ribal M.J., Alcaraz A.

Institutes: Universitary Clinic Hospital of Barcelona, Dept. of Urology, Barcelona, Spain

1100
Management of follow-up detected potentially curable recurrence after (partial) nephrectomy in non-metastatic renal cell carcinoma (RCC) of low, intermediate and high risk

By: Kuijpers Y.2, Meijer R.2, Bosch R.2, Horenblas S.1, Bex A.1

Institutes: 1Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Dept. of Urology, Amsterdam, The Netherlands, 2University Hospital Utrecht, Dept. of Urology, Utrecht, The Netherlands

1101
Metastastic capacity of T1a renal cell carcinoma

By: Lee H.1, Kim T.J.1, Kwak C.2, Kim H.H.2, Lee S.E.1, Byun S-S.1, Hong S.K.1

Institutes: 1Seoul National University Bundang Hospital, Dept. of Urology, Seongnam, South Korea, 2Seoul National University Hospital, Dept. of Urology, Seoul, South Korea

Summary and context
 T.A. Leslie, Oxford (GB)